Read More 2 minute read M&A News News Oragenics Acquires Odyssey Health’s Neurological Drug Assets for Future Growth Key Highlights Oragenics acquires assets related to Odyssey Health’s neurological drugs, including ONP-002 for concussion treatment and ONP-001 for… byChris-Anne RoqueJanuary 3, 2024